These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 17560877)
21. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system. Triantafyllis AS; Bennett J; Pagourelias E; McCutcheon K; Adriaenssens T; Sinnaeve PR; Desmet W; Dubois C Cardiol J; 2018; 25(4):470-478. PubMed ID: 29240962 [TBL] [Abstract][Full Text] [Related]
22. First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results. Gil RJ; Vassiliev D; Michałek A; Kern A; Formuszewicz R; Dobrzycki S; Lesiak M; Wójcik J; Kardaszewicz P; Lekston A Kardiol Pol; 2012; 70(1):45-52. PubMed ID: 22267425 [TBL] [Abstract][Full Text] [Related]
23. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A; JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543 [TBL] [Abstract][Full Text] [Related]
24. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297 [TBL] [Abstract][Full Text] [Related]
26. Acute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter nonrandomized feasibility study. Ikeno F; Kim YH; Luna J; Condado JA; Colombo A; Grube E; Fitzgerald PJ; Park SJ; Yeung AC Catheter Cardiovasc Interv; 2006 Feb; 67(2):198-206. PubMed ID: 16404749 [TBL] [Abstract][Full Text] [Related]
27. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME; JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of simultaneous kissing stenting technique with sirolimus-eluting stent for large bifurcation coronary lesions. Kim YH; Park DW; Suh IW; Jang JS; Hwang ES; Jeong YH; Lee SW; Lee SW; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2007 Nov; 70(6):840-6. PubMed ID: 17621657 [TBL] [Abstract][Full Text] [Related]
29. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study. Zhang Q; Xu B; Yang YJ; Zhang RY; Li JP; Qiao SB; Zhang JS; Hu J; Qin XW; Hong T; Chen JL; Huo Y; Shen WF; Gao RL Chin Med J (Engl); 2007 Apr; 120(7):533-8. PubMed ID: 17442198 [TBL] [Abstract][Full Text] [Related]
30. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. Buysschaert I; Dubois CL; Dens J; Ormiston J; Worthley S; McClean D; Ottervanger JP; Meredith I; Uren N; Wijns W; Whitbourn R; Mehran R; Lansky AJ; Bichalska M; Meis S; Verheye S EuroIntervention; 2013 Sep; 9(5):573-81. PubMed ID: 24058075 [TBL] [Abstract][Full Text] [Related]
31. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585 [TBL] [Abstract][Full Text] [Related]
32. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP; JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique". Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334 [TBL] [Abstract][Full Text] [Related]
34. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. Ge L; Airoldi F; Iakovou I; Cosgrave J; Michev I; Sangiorgi GM; Montorfano M; Chieffo A; Carlino M; Corvaja N; Colombo A J Am Coll Cardiol; 2005 Aug; 46(4):613-20. PubMed ID: 16098424 [TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855 [TBL] [Abstract][Full Text] [Related]
36. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614 [TBL] [Abstract][Full Text] [Related]
37. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients. Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238 [TBL] [Abstract][Full Text] [Related]
38. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
39. True coronary bifurcation lesions: meta-analysis and review of literature. Athappan G; Ponniah T; Jeyaseelan L J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):103-10. PubMed ID: 19952947 [TBL] [Abstract][Full Text] [Related]
40. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Fajadet J; Wijns W; Laarman GJ; Kuck KH; Ormiston J; Münzel T; Popma JJ; Fitzgerald PJ; Bonan R; Kuntz RE; Minerva Cardioangiol; 2007 Feb; 55(1):1-18. PubMed ID: 17287679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]